What is Chimeric Antigen Receptor (CAR) T-Cell Therapy?

Category: Procedures


CAR T-Cell Therapy is the process of using adoptive cell transfer therapy on T-cells in patients. T-cells are collected from blood and modified to produce chimeric antigen receptors, allowing the CAR T-cells to recognize antigens on tumor cells. They are then multiplied and ready for infusion.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 0
Mild 2
None 0

Commonly reported side effects and conditions associated with Chimeric Antigen Receptor (CAR) T-Cell Therapy

Side effect Patients Percentage
IgG deficiency 1
Adherence Evaluations Percentage
Always 2
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 1
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 2
Not specified 0

What people switch to and from

Patients started having Chimeric Antigen Receptor (CAR) T-Cell Therapy after stopping:

Treatment Patients Percentage
Rituximab (Rituxan) 1
Last updated:
There are no evaluations for Chimeric Antigen Receptor (CAR) T-Cell Therapy.